Pfizer and Israeli company Teva were the only manufacturers of Vincristine until July 2019, when Teva made a “business decision” to stop producing the drug, leaving Pfizer as the sole U.S. producer. (Photo: John R. Perry, Pixabay)
“The average price of vincristine in the developing world, where it is on the World Health Organization’s list of essential medicines, is $1.80 a dose, compared to $42.60 per dose in the U.S.”
Keep the story going. Sign up for an extra free read.
You've completed your member preview for this month, but when you sign up for a free Medium account, you get one more story.